The US Food and Drug Administration (FDA) has officially approved Bristol Myers Squibb’s latest oral medication, Cobenfy, for the treatment of schizophrenia in adults. …
Magazine
info@luminarytimes.com
+1-8308642693
©2023 Luminary Times. All rights Reserved.
Tag:
At Luminary Times, our mission is to shine a light on the luminaries who are paving the way towards a brighter future. As the largest online business magazine community platform, we strive to share insights into the success of solution and service providers on a global scale.
